Skip to main content

Table 1 Preoperative patient and tumor-related variables

From: Cirrhosis is not a contraindication to cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in highly selected patients

 

Patient 1

Patient 2

Patient 3

Age (years)

49

59

44

Gender

M

M

F

Disease type

LAMN

LAMN with focal high grade

Malignant mesothelioma

ECOG

0

0

0

ASA class

III

III

IV

BMI (kg/m2)

37

24

32

Symptoms

None

None (right lower quadrant pain prompted laparoscopic appendectomy turned right hemicolectomy)

Weight loss, abdominal distension, lower extremity edema

Etiology of cirrhosis

HCV

Alcohol

HCV cirrhosis, GT1a

Bilirubin

0.5

0.51

0.3

INR

1.2

1.1

1.0

Ascites (yes/no)

No

No

Yes

Child’s class

A

A

A

Platelet count

164

207

259

Portal hypertension

No

Yes

No

MELD score

8

8

6

Treatment for hepatitis C/cirrhosis

None

Alcohol cessation, propranolol for gastric varices

None

Other significant PMH

HTN, non-insulin-dependent diabetes

None

Insulin-dependent diabetes

  1. ECOG Eastern Cooperative Oncology Group, ASA American Society of Anesthesiology, BMI body mass index, INR international normalized ratio, MELD model for end-stage liver disease, PMH past medical history